306 related articles for article (PubMed ID: 14612531)
21. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
22. Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
Alli PM; Pinn ML; Jaffee EM; McFadden JM; Kuhajda FP
Oncogene; 2005 Jan; 24(1):39-46. PubMed ID: 15489885
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
24. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells.
Brusselmans K; De Schrijver E; Verhoeven G; Swinnen JV
Cancer Res; 2005 Aug; 65(15):6719-25. PubMed ID: 16061653
[TBL] [Abstract][Full Text] [Related]
25. The connections between C75 and obesity drug-target pathways.
Kuhajda FP; Landree LE; Ronnett GV
Trends Pharmacol Sci; 2005 Nov; 26(11):541-4. PubMed ID: 16169094
[TBL] [Abstract][Full Text] [Related]
26. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
Hu Z; Cha SH; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12624-9. PubMed ID: 14532332
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Aug; 180(2):729-36. PubMed ID: 18555493
[TBL] [Abstract][Full Text] [Related]
28. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
[TBL] [Abstract][Full Text] [Related]
29. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects.
Hu Z; Cha SH; van Haasteren G; Wang J; Lane MD
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3972-7. PubMed ID: 15728730
[TBL] [Abstract][Full Text] [Related]
30. Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.
Puig T; Relat J; Marrero PF; Haro D; Brunet J; Colomer R
Anticancer Res; 2008; 28(6A):3671-6. PubMed ID: 19189648
[TBL] [Abstract][Full Text] [Related]
31. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
33. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
Hsu YL; Kuo PL; Lin LT; Lin CC
J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
[TBL] [Abstract][Full Text] [Related]
34. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.
Landree LE; Hanlon AL; Strong DW; Rumbaugh G; Miller IM; Thupari JN; Connolly EC; Huganir RL; Richardson C; Witters LA; Kuhajda FP; Ronnett GV
J Biol Chem; 2004 Jan; 279(5):3817-27. PubMed ID: 14615481
[TBL] [Abstract][Full Text] [Related]
35. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.
Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G
Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373
[TBL] [Abstract][Full Text] [Related]
36. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment.
Kim EK; Miller I; Landree LE; Borisy-Rudin FF; Brown P; Tihan T; Townsend CA; Witters LA; Moran TH; Kuhajda FP; Ronnett GV
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E867-79. PubMed ID: 12376313
[TBL] [Abstract][Full Text] [Related]
37. C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.
Mera P; Bentebibel A; López-Viñas E; Cordente AG; Gurunathan C; Sebastián D; Vázquez I; Herrero L; Ariza X; Gómez-Puertas P; Asins G; Serra D; García J; Hegardt FG
Biochem Pharmacol; 2009 Mar; 77(6):1084-95. PubMed ID: 19094968
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
Cha SH; Hu Z; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
[TBL] [Abstract][Full Text] [Related]
39. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.
Chajès V; Cambot M; Moreau K; Lenoir GM; Joulin V
Cancer Res; 2006 May; 66(10):5287-94. PubMed ID: 16707454
[TBL] [Abstract][Full Text] [Related]
40. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA
Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]